The presence of Epstein-Barr virus (EBV) DNA sequences was examined by the polymerase chain reaction in 50 nasopharyngeal carcinoma (NPC) biopsy specimens and in two primary epithelial tumor cell cultures derived from patients with NPC. The detection limit was a single EBV genome equivalent by agarose gel electrophoresis followed by Southern blot analysis of the amplified products. EBV DNA sequences were detected in all 41 undifferentiated NPC cell specimens, in 2 of 4 moderately differentiated NPC cell specimens, and in 3 of 5 keratinized NPC cell specimens. Undifferentiated NPC cells were also found to contain higher copy numbers of EBV than cells of the other two types of NPC. Our data suggest that EBV replication may be closely associated with the differentiation of NPC tumor cells. The results also demonstrated a sensitive and specific method for the detection of EBV DNA sequences in NPC tumor cells.
Epstein-Barr virus (EBV), a ubiquitous human herpesvirus, is the causative agent of infectious mononucleosis (5) and has been suggested to be closely related to at least three human cancers, Burkitt's lymphoma (6, 7) , nasopharyngeal carcinoma (NPC) (7, 8) , and lymphoma in immunocompromised individuals. NPC is one of the most common cancers of males in southeastern Asia, including southern China and Taiwan. EBV DNA has been detected in endemic Burkitt's lymphoma (12) , in NPC tissues (10) , and in cell lines derived from NPC by Southern blot hybridization (2) . Fahraeus et al. reported the presence of EBV DNA in 90% of NPC tissues examined (4) . However, it is technically difficult to analyze the EBV in NPC tissues because of specimen size, and there has been no report correlating the presence and the content of EBV DNA in different stages of NPC.
Recently, a powerful technique known as the polymerase chain reaction (PCR), which is capable of amplifying specific DNA by making thousands of copies in a matter of hours in vitro, was described. PCR is based on repeated cycles of template denaturation coupled with highly specific oligonucleotide primers to extend the DNA chain with the assistance of a thermostable enzyme, Taq polymerase (15) . The primers are positioned so that the products of each cycle can serve as a template for the next cycle of DNA extension, which can result in exponential accumulation of the DNA bracketed by the two primers. Amplification of specific target DNA by PCR allows the use of very small amounts of target DNA and permits easy identification of product DNA after amplification (15) .
In the following text we describe the use of PCR to detect the presence and determine the content of EBV DNA in various types of NPC cells. b The EBV content in all the biopsy tissues was estimated as described in the text. <1 indicates that the EBV content was below the detection limit of the method used.
MATERIALS
overnight. DNA was then purified by repeated phenolchloroform-isoamyl alcohol (49:49:2) extraction followed by ethanol precipitation.
PCR assays and primers. Purified sample DNA was subjected to PCR amplification in a thermal cycler (Coy Laboratory Products, Inc., Ann Arbor, Mich.). Three sets of EBV-specific oligonucleotide primers corresponding to the BamHI Nhet, Y, and E fragments of strain were prepared and used in this study. The sequences of these primers and the locations and distance bracketed by each set of primers are shown in Fig. 1 . A typical 100-,ul amplification reaction mixture contained 10 mM Tris (pH 7.5), 50 mM NaCl, 10 mM NgCl2, the four deoxyribonucleoside triphosphates (1.5 mM each), the two primers (1 ,uM each), and 2.5 U of Taq DNA polymerase. The amplification procedure included 3 min of denaturation at 95°C in the first cycle (1 min thereafter) followed by 2 (3) . The hybridization conditions followed the procedure recommended by Maniatis et al. (13) .
Estimation of detection limit and EBV copy number. The detection limit of EBV DNA by PCR was determined by positive identification of EBV DNA in serial dilutions of DNA prepared from pBamHI-E and Namalwa cells. Plasmid pBamHI-E contained a 7.9-kb BamHI E fragment of EBV strain B95-8 in the BamHI site of pBR322 (19) . Namalwa cells contained two genome equivalents of EBV per cell (11) .
Estimation of EBV DNA content in NPC biopsy specimens. One microgram of biopsy DNA and 10-fold dilutions thereof were subjected to PCR analysis. The amplification using primer set E, we were able to detect EBV DNA sequences in 0.5 ng of Namalwa cell DNA. On the basis of the facts that Namalwa cells contain two copies of the EBV genome in each cell (11) , that the genome size of EBV is 172,282 bp, and that the size of the human genome is about 3 x 109 bp, the PCR detection limit is approximately 250 genome equivalents of EBV per cell (Fig. 2A, lane 6 ). An additional 32 cycles of PCR with the same primers (data not shown) or Southern blot hybridization of the products from the first 32 cycles of amplification can increase the sensitivity of detection of EBV DNA by PCR by at least 500-fold (Fig.  2B, lane 9) , which brings the detection limit down to approximately a single EBV genome equivalent. When the cloned EBV fragment was used as a template, the sensitivity increased to 10-5 pg (data not shown). This result is similar to the limit established for the detection of hepatitis B virus DNA sequences in serum (9 three NPC biopsy tissue specimens and in two primary cell cultures previously shown to contain EBV (Fig. 3A and B , lanes 4 to 6, 8, and 9) as well as in B95-8, Raji, and Namalwa cells (Fig. 3A and B, lanes 1 to 3) . The hybridization band of specimen 155P (Fig. 3B, lane 9) , which was derived from an EBV-positive WHO type 3 tumor, was very light. It was probably due to poor transfer of DNA from the agarose gel. This 225-bp DNA fragment was cloned into pUC18 and was demonstrated to be EBV sequence (data not shown). All NPC biopsy tissues and cultured cells derived from NPC were also analyzed with primer sets C and E by PCR. All the EBV-positive samples shared positive results and gave 316-bp (primer set C) and 454-bp (primer set E) bands. The PCR products of DNA samples positive for all three sets of primers were considered EBV positive ( (Table 1) . However, EBV DNA was found in one of six normal nasopharyngeal tissue specimens and in one of four biopsy specimens of hypopharyngeal carcinoma tissues. All these findings were consistent with the recent suggestion that the permissive cell types for EBV replication also include epithelial cells (1) .
EBV DNA content in NPC tissues. The amount of EBV DNA in NPC specimens that contain EBV was estimated by comparison with that in Namalwa cells, which were shown to contain two copies of EBV per cell (11) (18) . It has also been reported that only EBNA1 protein can be consistently detected in NPC tissues (4) . The presence of this protein in the tumor tissues presumably permits the replication of the viral genome in cells. Our data suggest that EBV replication is regulated with cell differentiation, as evidenced by the presence of significantly higher EBV DNA contents in type 3 NPCs and lower EBV DNA contents in type 1 and type 2 NPCs. These data seem to imply that EBV DNA replication was favorable in undifferentiated epithelial cells. This is in agreement with the earlier reports that expression of productive-cycle viral antigens (early antigens and viral capsid antigen) and virions were restricted to terminally differentiated cells such as desquamated epithelial cells in pharyngeal washing (16) and that EBV replication occured in undifferentiated epithelial cells (1) .
The positivity of EBV DNA in hypopharyngeal carcinoma is probably not statistically different from that in WHO type 1 and 2 NPCs. Other non-NPC tumors (palate carcinoma, maxillary carcinoma, and tongue carcinoma) were classified as keratinizing squamous-cell carcinomas and were also associated with lower contents of EBV DNA in their tissues.
The amount of DNA obtained from two primary cultures (122P and 155P) was limited. Therefore, no serial dilutions of DNA were performed to determine the EBV DNA content quantitatively. Ideally, establishing an EBV-containing NPC cell line will allow us to circumvent this problem. In summary, by using PCR we were able to demonstrate the direct detection of wide ranges of EBV DNA at low levels in three types of NPC cells. Our data also suggest that EBV replication in nasopharyngeal epithelial cells seems to be related to the differentiation stages of the NPC cells. In light of this, understanding and assessing the correlation of these points become important for understanding EBV pathogenesis. It has been suggested that uncontrolled EBV replication in the pharyngeal epithelium may be central to the evolution of some (or all) EBV-associated malignancies (1) . To further examine this correlation, it seems reasonable to look at the replication-associated antigens as well as the latent proteins of EBV in different types of NPCs. Additionally, other factors (cellular or viral) in differentiated cells that may suppress EBV replication are worth investigating. Identification of these genes may be essential for understanding the role of EBV in NPC tumorigenesis. With the availability of PCR, it will be feasible to perform reverse transcription on and amplify RNA from small numbers of tumor cells.
